~~<i id='821F00E226'><strike id='821F00E226'><tt id='821F00E226'><pre id='821F00E226'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：focus 2025-10-01 04:10:45 - browse：2714

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

explore

focus

leisure time

focus

entertainment

HasAIreallysolvedbiology?Whatcanmachinesteachusaboutmedicine?Andwhat’sadigitaltwin?Wecoverallthatand

WSS

Using force crossed my mind when examining a defiant young patient

Pfizer is about to make a big push in cancer. Will investors listen?

Medicare Advantage proposed rates disappoint insurers

'Revelatory' study finds a smoking impact that remains after quitting

Are embryos people? Reproductive medicine's future depends on the answer

Key House Republican on health care plans exit from Congress

focus

Wikipedia

explore

The cancer drug shortage isn’t new — and neither are the solutions

'Vaccine

What does generative AI mean for health care? We asked experts

5 ways to address the shortage of health care workers

Bright Health sells Medicare Advantage business to Molina

CDC advisory group OKs chikungunya vaccine

Walensky prepares to leave CDC — and Congress — behind

What should King Charles tell the public about his cancer?

Medicare proposal to cover medical devices draws a mixed reaction

What should King Charles tell the public about his cancer?

focus

BioAge raises $170M for combination therapy with Zepbound

Change Healthcare cyberattack shows risk of industry consolidation

Doctors' information doesn't help them choose wisely when sick

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Cholera vaccine supplies dangerously low, outbreaks surging

How digital tools helped lower hypertension in marginalized patients

leisure time

leisure time

focus

entertainment